Patients were admitted as of the date of the last annual review under this protocol. As of July, 1999, a second protocol, looking at the use of long-acting somatostatin in acromegaly, has been completed and discontinued. As of September 1999, a new protocol, comparing long- acting somatostatin versus surgery for pituitary macroadenomas has begun under Dr. Derek LeRoith. - acromegaly, growth hormone - Human Subjects

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Intramural Research (Z01)
Project #
1Z01DK055021-01
Application #
6227931
Study Section
Special Emphasis Panel (CEB)
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code